Shared mechanisms across the major psychiatric and neurodegenerative diseases

[1]  R. Mosharraf,et al.  An Umbrella Review of Systematic Reviews and Meta-Analyses Evaluating the Success Rate of Prosthetic Restorations on Endodontically Treated Teeth , 2022, International journal of dentistry.

[2]  A. Caspi,et al.  Longitudinal Associations of Mental Disorders With Dementia , 2022, JAMA psychiatry.

[3]  A. Wingo,et al.  Large‐scale deep multi‐layer analysis of Alzheimer’s disease brain reveals strong proteomic disease‐related changes not observed at the RNA level , 2021, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[4]  D. Duong,et al.  Heterogeneous Expression of Nuclear Encoded Mitochondrial Genes Distinguishes Inhibitory and Excitatory Neurons , 2021, eNeuro.

[5]  G. Ming,et al.  Seq-ing out cell types across the isocortex and hippocampal formation , 2021, Cell.

[6]  V. Reus.  Faculty Opinions recommendation of Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[7]  Emilia M. Wysocka,et al.  A unified resource and configurable model of the synapse proteome and its role in disease , 2021, Scientific Reports.

[8]  S. Cavallaro,et al.  Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases , 2021, International journal of molecular sciences.

[9]  Azzurra Margiotta.  Role of SNAREs in Neurodegenerative Diseases , 2021, Cells.

[10]  Benjamin A. Logsdon,et al.  Brain proteome-wide association study implicates novel proteins in depression pathogenesis , 2021, Nature Neuroscience.

[11]  Daniel J. Gaffney,et al.  Genome-wide meta-analysis, fine-mapping, and integrative prioritization implicate new Alzheimer’s disease risk genes , 2021, Nature Genetics.

[12]  Luochao Zhang,et al.  Dysfunction of the SNARE complex in neurological and psychiatric disorders. , 2021, Pharmacological research.

[13]  Benjamin A. Logsdon,et al.  Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis , 2021, Nature Genetics.

[14]  Hongyu Zhao,et al.  Genome-wide association analyses of posttraumatic stress disorder and its symptom subdomains in the Million Veteran Program , 2021, Nature Genetics.

[15]  Sonja W. Scholz,et al.  Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture , 2021, Nature Genetics.

[16]  N. Eriksson,et al.  Cerebral small vessel disease genomics and its implications across the lifespan , 2020, Nature Communications.

[17]  Alexander R. Pico,et al.  WikiPathways: connecting communities , 2020, Nucleic Acids Res..

[18]  Apekshya Panda,et al.  MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations , 2020, Nucleic Acids Res..

[19]  Kara Dolinski,et al.  The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactions , 2020, Protein science : a publication of the Protein Society.

[20]  V. Haroutunian,et al.  Molecular signature of extracellular matrix pathology in schizophrenia , 2020, The European journal of neuroscience.

[21]  Benjamin A. Logsdon,et al.  Multi-tissue neocortical transcriptome-wide association study implicates 8 genes across 6 genomic loci in Alzheimer’s disease , 2020, Genome Medicine.

[22]  A. McQuillin,et al.  Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits , 2020, Nature Neuroscience.

[23]  A. Wingo,et al.  Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain , 2020, Nature Neuroscience.

[24]  E. Shoubridge,et al.  A high-density human mitochondrial proximity interaction network , 2020, bioRxiv.

[25]  Hongkui Zeng,et al.  A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation , 2020, Cell.

[26]  Anders M. Dale,et al.  The genetic architecture of the human cerebral cortex , 2020, Science.

[27]  O. Wiborg,et al.  Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer’s Disease: Insights From Preclinical Models, Clinical Data, and Future Directions , 2020, Frontiers in Aging Neuroscience.

[28]  S. Djurovic,et al.  Genome-wide Association Analysis of Parkinson’s Disease and Schizophrenia Reveals Shared Genetic Architecture and Identifies Novel Risk Loci , 2020, Biological Psychiatry.

[29]  P. Sullivan,et al.  Reproducible Genetic Risk Loci for Anxiety: Results From ∼200,000 Participants in the Million Veteran Program. , 2020, The American journal of psychiatry.

[30]  Bin Zhang,et al.  Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression , 2020, Neuron.

[31]  J. Das.  SNARE complex-associated proteins and alcohol. , 2019, Alcoholism, clinical and experimental research.

[32]  Benjamin S Aribisala,et al.  Genetic architecture of subcortical brain structures in 38,851 individuals , 2019, Nature Genetics.

[33]  Mark R. Hurle,et al.  Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases , 2019, bioRxiv.

[34]  Manolis Kellis,et al.  Single-cell transcriptomic analysis of Alzheimer’s disease , 2019, Nature.

[35]  Benjamin A. Logsdon,et al.  Gene expression imputation across multiple brain regions provides insights into schizophrenia risk , 2019, Nature Genetics.

[36]  Genetic,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[37]  Nick C Fox,et al.  Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing , 2019, Nature Genetics.

[38]  V. Vacic,et al.  Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways , 2019, Nature Genetics.

[39]  Hunna J. Watson,et al.  Genome wide meta-analysis identifies genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders , 2019, bioRxiv.

[40]  Jacob F. Degner,et al.  Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval , 2019, bioRxiv.

[41]  Timothy J. Hohman,et al.  Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.

[42]  Annie W Shieh,et al.  Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder , 2018, Science.

[43]  Stephan J Sanders,et al.  Integrative functional genomic analysis of human brain development and neuropsychiatric risks , 2018, Science.

[44]  Andreas Ruepp,et al.  CORUM: the comprehensive resource of mammalian protein complexes—2019 , 2018, Nucleic Acids Res..

[45]  Brielin C. Brown,et al.  Comparative genetic architectures of schizophrenia in East Asian and European populations , 2018, Nature Genetics.

[46]  R. Marioni,et al.  Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions , 2018, Nature Neuroscience.

[47]  A. Levey,et al.  Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease , 2018, Molecular Neurodegeneration.

[48]  Benjamin A. Logsdon,et al.  The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease , 2018, Scientific Data.

[49]  Laisheng Cai,et al.  Schizophrenia and risk of dementia: a meta-analysis study , 2018, Neuropsychiatric disease and treatment.

[50]  R. Rapee,et al.  Anxiety disorders , 2018, Nature Reviews Disease Primers.

[51]  Ronald J. Moore,et al.  Reproducible workflow for multiplexed deep-scale proteome and phosphoproteome analysis of tumor tissues by liquid chromatography–mass spectrometry , 2018, Nature Protocols.

[52]  S. Linnarsson,et al.  Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways , 2018, Nature Genetics.

[53]  David A Bennett,et al.  Religious Orders Study and Rush Memory and Aging Project. , 2018, Journal of Alzheimer's disease : JAD.

[54]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[55]  J. Huntley,et al.  Support for midlife anxiety diagnosis as an independent risk factor for dementia: a systematic review , 2018, BMJ Open.

[56]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.

[57]  A. Levey,et al.  Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease , 2018, Scientific Data.

[58]  Charles C. White,et al.  A transcriptomic atlas of aged human microglia , 2018, Nature Communications.

[59]  H. Akil,et al.  Treatment resistant depression: A multi-scale, systems biology approach , 2018, Neuroscience & Biobehavioral Reviews.

[60]  Charles C. White,et al.  A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research , 2018, bioRxiv.

[61]  Michael J. Devine,et al.  Mitochondria at the neuronal presynapse in health and disease , 2018, Nature Reviews Neuroscience.

[62]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[63]  Jakob Grove,et al.  Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder , 2017, bioRxiv.

[64]  M. Friedrich.  Depression Is the Leading Cause of Disability Around the World. , 2017, JAMA.

[65]  J. Ioannidis,et al.  Systematic evaluation of the associations between environmental risk factors and dementia: An umbrella review of systematic reviews and meta-analyses , 2017, Alzheimer's & Dementia.

[66]  Grant D. Huang,et al.  It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group , 2017, Biological Psychiatry.

[67]  Madhav Thambisetty,et al.  A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease. , 2017, Cell systems.

[68]  R. Sweet,et al.  Genetics of psychosis of Alzheimer disease , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[69]  C. Brayne,et al.  Longitudinal course of behavioural and psychological symptoms of dementia: systematic review , 2016, British Journal of Psychiatry.

[70]  C. Cotman,et al.  Nuclear but not mitochondrial-encoded oxidative phosphorylation genes are altered in aging, mild cognitive impairment, and Alzheimer's disease , 2016, Alzheimer's & Dementia.

[71]  Tingting Zhao,et al.  Systematically characterizing dysfunctional long intergenic non-coding RNAs in multiple brain regions of major psychosis , 2016, Oncotarget.

[72]  G. Hankey,et al.  Risk of dementia and death in community-dwelling older men with bipolar disorder. , 2016, The British journal of psychiatry : the journal of mental science.

[73]  Nick C Fox,et al.  Analysis of shared heritability in common disorders of the brain , 2018, Science.

[74]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[75]  S. Horvath,et al.  Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap , 2016, Science.

[76]  Matthias Mann,et al.  Cell type– and brain region–resolved mouse brain proteome , 2015, Nature Neuroscience.

[77]  T. Lehtimäki,et al.  Integrative approaches for large-scale transcriptome-wide association studies , 2015, Nature Genetics.

[78]  H. Shill,et al.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program , 2015, Neuropathology : official journal of the Japanese Society of Neuropathology.

[79]  田原 康玄,et al.  生活習慣病とgenome-wide association study , 2015 .

[80]  Alexander Gerhard,et al.  Frontotemporal dementia and its subtypes: a genome-wide association study , 2014, The Lancet Neurology.

[81]  P. Murray,et al.  Psychosis in Alzheimer’s Disease , 2014, Biological Psychiatry.

[82]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[83]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[84]  R. Tanzi,et al.  ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function , 2013, Neuron.

[85]  L. Siever,et al.  Spatial and Temporal Mapping of De Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network , 2013, Cell.

[86]  C. Wallace,et al.  Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.

[87]  Allan R. Jones,et al.  An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.

[88]  Chris T. A. Evelo,et al.  Bioinformatics Applications Note Databases and Ontologies Go-elite: a Flexible Solution for Pathway and Ontology Over-representation , 2022 .

[89]  Jason J. Corneveaux,et al.  A genome-wide scan for common variants affecting the rate of age-related cognitive decline , 2012, Neurobiology of Aging.

[90]  E. Marcotte,et al.  Insights into the regulation of protein abundance from proteomic and transcriptomic analyses , 2012, Nature Reviews Genetics.

[91]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[92]  Josyf Mychaleckyj,et al.  Robust relationship inference in genome-wide association studies , 2010, Bioinform..

[93]  G. McKhann,et al.  Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model , 2010, Proceedings of the National Academy of Sciences.

[94]  P. Reddy,et al.  Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline. , 2010, Journal of Alzheimer's disease : JAD.

[95]  W. Kamphorst,et al.  Comprehensive mRNA Expression Profiling Distinguishes Tauopathies and Identifies Shared Molecular Pathways , 2009, PloS one.

[96]  John P A Ioannidis,et al.  Meta-analysis in genome-wide association studies. , 2009, Pharmacogenomics.

[97]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[98]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[99]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[100]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[101]  T. Mackenzie,et al.  Prevalence and treatment of mental disorders. , 2005, The New England journal of medicine.

[102]  Harold Alan Pincus,et al.  Prevalence and treatment of mental disorders, 1990 to 2003. , 2005, The New England journal of medicine.

[103]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[104]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[105]  L A Beckett,et al.  Hallucinations, delusions, and cognitive decline in Alzheimer's disease , 2000, Journal of neurology, neurosurgery, and psychiatry.

[106]  A. Caspi,et al.  Longitudinal Associations of Mental Disorders With Dementia 30-Year Analysis of 1.7 Million New Zealand Citizens , 2022 .

[107]  N. Herrmann,et al.  The Interplay Between Post-traumatic Stress Disorder and Dementia: A Systematic Review. , 2019, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[108]  William C. Bennett,et al.  Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. , 2018, Scientific data.

[109]  Kai-Uwe Eckardt,et al.  Novel genetic loci associated with hippocampal , 2017 .

[110]  M. Nalls,et al.  Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data , 2016, The Lancet Neurology.

[111]  E. Reiman,et al.  Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene. , 2010, Journal of Alzheimer's disease : JAD.

[112]  R. Kessler,et al.  Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. , 1994, Archives of general psychiatry.

[113]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .